Results 1 to 10 of about 6,682 (214)

Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice [PDF]

Frontiers in Neurology, 2019
Purpose: Cardiac [123I]metaiodobenzylguanidine scintigraphy (123I-MIBG), reflecting postganglionic cardiac autonomic denervation, is proposed for early detection of Parkinson's disease (PD; reduced tracer uptake) and separation from Multiple System ...
Cornelia Skowronek, Cornelia Skowronek, Leonora Zange, Leonora Zange, Axel Lipp, Axel Lipp   +5 more
doaj   +7 more sources

MIBG Scintigraphy and Arrhythmic Risk in Myocarditis [PDF]

Biomedicines
Background: The widespread use of cardiac magnetic resonance imaging (MRI) in clinical practice has enabled the identification of numerous patients with evident damage from previous myocarditis, whether known or unknown.
Maria Lo Monaco, Margherita Licastro, Matteo Nardin, Rocco Mollace, Flavia Nicoli, Alessandro Nudi, Giuseppe Medolago, Erika Bertella   +7 more
doaj   +7 more sources

Potential Utility of 123I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease [PDF]

Frontiers in Neurology, 2019
Background: Falls are associated with poor prognosis in patients with Parkinson's disease (PD). Although several factors related to falls were reported in patients with PD, objective predictors of falls are not identified.
Wataru Sako
exaly   +4 more sources

The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation. [PDF]

Eur Heart J Cardiovasc Imaging, 2021
Cardiac resynchronization therapy (CRT) is a disease-modifying therapy in patients with chronic heart failure (CHF). Current guidelines ascribe CRT eligibility on three parameters only: left ventricular ejection fraction (LVEF), QRS duration, and New ...
Verschure DO, Poel E, De Vincentis G, Frantellizzi V, Nakajima K, Gheysens O, de Groot JR, Verberne HJ.   +7 more
europepmc   +3 more sources

Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review [PDF]

Brain Sciences, 2023
Cardiac sympathetic denervation, as documented on 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy, is relatively sensitive and specific for distinguishing Parkinson’s disease (PD) from other neurodegenerative causes of parkinsonism.
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara   +1 more
doaj   +2 more sources

Value of multi-parameter 123I-MIBG scintigraphy in the differential diagnosis of Parkinson’s disease [PDF]

EJNMMI Research
Background 123I-MIBG scintigraphy plays a significant role in diagnosing Parkinson's disease (PD), with most studies primarily targeting cardiac uptake and relying on traditional ratio-based parameters for assessment.
Teng Xue, Ying Cui, Ying Kan, Guanyun Wang, Jigang Yang   +4 more
doaj   +2 more sources

Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy [PDF]

Clinical Parkinsonism & Related Disorders, 2020
Background: An early clinical differentiation between Parkinson's disease (PD) and multiple system atrophy (MSA) or progressive supranuclear palsy (PSP) remains a challenge.
Hirotaka Sakuramoto, Hiroaki Fujita, Keisuke Suzuki, Takeo Matsubara, Yuji Watanabe, Mai Hamaguchi, Koichi Hirata   +6 more
doaj   +2 more sources

Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy [PDF]

npj Parkinson's Disease, 2020
[18F]fluorodeoxyglucose (FDG) PET and [123I]metaiodobenzylguanidine (MIBG) scintigraphy may contribute to the differential diagnosis of neurodegenerative parkinsonism.
Joachim Brumberg, Nils Schröter, Ganna Blazhenets, Lars Frings, Jens Volkmann, Constantin Lapa, Wolfgang H. Jost, Ioannis U. Isaias, Philipp T. Meyer   +8 more
doaj   +2 more sources

Urinary Dopamine Levels Can Predict the Avidity of Post-Therapy [¹³¹I]MIBG Scintigraphy in Unresectable or Metastatic Pheochromocytomas and Paragangliomas: A Preliminary Clinical Study [PDF]

Pharmaceuticals
Background/Objectives: Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that produce catecholamines. Unresectable or metastatic PPGLs are treated with [131I]metaiodobenzylguanidine (MIBG), but MIBG avidity is often ...
Junki Takenaka, Shiro Watanabe, Takashige Abe, Satoshi Takeuchi, Kenji Hirata, Rina Kimura, Hiroshi Ishii, Naoto Wakabayashi, Mungunkhuyag Majigsuren, Kohsuke Kudo   +9 more
doaj   +2 more sources

[¹²³I]-Meta-Iodobenzylguanidine Scintigraphy in Sarcoidosis: Exploring Cardiac Autonomic Dysfunction in Patients with Unexplained Cardiac Symptoms [PDF]

Diagnostics
Background/Objectives: Sarcoidosis is a systemic inflammatory disease that can cause cardiac autonomic dysfunction (SCAD), often underrecognized despite its clinical importance.
Lisette R. M. Raasing, Marjolein Drent, Ruth G. M. Keijsers, Andor F. van den Hoven, Marco C. Post, Jan C. Grutters, Marcel Veltkamp   +6 more
doaj   +2 more sources